Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodies.

@article{Behr1996ThyroidRD,
  title={Thyroid radiation doses during radioimmunotherapy of CEA-expressing tumours with 131I-labelled monoclonal antibodies.},
  author={T. M. Behr and Malik E. Juweid and Robert M Sharkey and Robert M. Dunn and Z. Ying and Wendy S Becker and Jeffry A. Siegel and David M. Goldenberg},
  journal={Nuclear medicine communications},
  year={1996},
  volume={17 9},
  pages={767-80}
}
A number of radioimmunotherapy (RAIT) trials with iodinated antibodies have shown a high variability in the radiation doses to the thyroid. Therefore, the aim of this study was to evaluate which factors influence these thyroid doses during RAIT with 131iodinated monoclonal anti-carcinoembryonic antigen (CEA) antibodies. Data from 36 patients with CEA… CONTINUE READING